УНИВЕРСИТЕТСКА СПЕЦИАЛИЗИРАНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ ПО ОНКОЛОГИЯ "ПРОФ. ИВАН ЧЕРНОЗЕМСКИ" ЕАД

Clement What the numbers say about this buyer

• 74% of this buyer's awards went to companies that had already won here before (690 awards since 2022, spread over 169 companies). That is well above the national norm (59%) — newcomers have a harder time here than elsewhere.n = 690 awards since 2022
• The award came in at a median 52% of the estimated value (61 awards with both estimate and value) — pricing at the estimate is usually too high here. Country: 73%.n = 61
• The median procedure drew 2 bids (525 procedures with a bid count); 36% ended with a single bidder. Country: median 1.9 bids.n = 525
• Not one of the 690 awards with a known winner country has gone to a foreign company so far. National average: 6%.n = 690
• Across 8 procedures with structured selection criteria, this buyer most often required: Professional register enrolment (8 of 8), Minimum annual turnover (5 of 8), Staff qualifications (2 of 8), Independent quality certificate (e.g. ISO 9001) (2 of 8).n = 8
• 21% of the bids received came from small and medium-sized enterprises (180 procedures with a bid mix). Country: 16%.n = 180
• < 1% of the bids received came from other countries (180 procedures with a bid mix) — all bidders, not just the winners. Country: 0%.n = 180

From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 01/11/2026.